• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

MDC1在功能上被鉴定为雄激素受体共激活因子,参与前列腺癌的抑制过程。

MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer.

作者信息

Wang Chunyu, Sun Hongmiao, Zou Renlong, Zhou Tingting, Wang Shengli, Sun Shiying, Tong Changci, Luo Hao, Li Yanshu, Li Zhenhua, Wang Enhua, Chen Yuhua, Cao Liu, Li Feng, Zhao Yue

机构信息

Department of Cell Biology, Key laboratory of Cell Biology, Ministry of Public Health, and Key laboratory of Medical Cell Biology, Ministry of Education, China Medical University, Shenyang, Liaoning 110122, China.

Department of Urology, the First Affiliated Hospital, China Medical University, Shenyang, Liaoning 110001, China.

出版信息

Nucleic Acids Res. 2015 May 26;43(10):4893-908. doi: 10.1093/nar/gkv394. Epub 2015 Apr 30.

DOI:10.1093/nar/gkv394
PMID:25934801
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4446443/
Abstract

Mediator of DNA damage checkpoint protein 1 (MDC1) is essential for DNA damage response. However, the role of MDC1 in modulating gene transcription independently of DNA damage and the underlying mechanisms have not been fully defined. Androgen receptor (AR) is the central signaling pathway in prostate cancer (PCa) and its target genes are involved in both promotion and suppression of PCa. Here, we functionally identified MDC1 as a co-activator of AR. We demonstrate that MDC1 facilitates the association between AR and histone acetyltransferase GCN5, thereby increasing histone H3 acetylation level on cis-regulatory elements of AR target genes. MDC1 knockdown promotes PCa cells growth and migration. Moreover, depletion of MDC1 results in decreased expression of a subset of the endogenous androgen-induced target genes, including cell cycle negative regulator p21 and PCa metastasis inhibitor Vinculin, in AR positive PCa cell lines. Finally, the expression of MDC1 and p21 correlates negatively with aggressive phenotype of clinical PCa. These studies suggest that MDC1 as an epigenetic modifier regulates AR transcriptional activity and MDC1 may function as a tumor suppressor of PCa, and provide new insight into co-factor-AR-signaling pathway mechanism and a better understanding of the function of MDC1 on PCa.

摘要

DNA损伤检查点蛋白1(MDC1)是DNA损伤反应所必需的。然而,MDC1在独立于DNA损伤的情况下调节基因转录的作用及其潜在机制尚未完全明确。雄激素受体(AR)是前列腺癌(PCa)的核心信号通路,其靶基因参与PCa的促进和抑制。在这里,我们在功能上鉴定MDC1为AR的共激活因子。我们证明MDC1促进AR与组蛋白乙酰转移酶GCN5之间的结合,从而增加AR靶基因顺式调控元件上的组蛋白H3乙酰化水平。MDC1敲低促进PCa细胞的生长和迁移。此外,在AR阳性PCa细胞系中,MDC1的缺失导致内源性雄激素诱导的靶基因子集的表达降低,包括细胞周期负调节因子p21和PCa转移抑制因子纽蛋白。最后,MDC1和p21的表达与临床PCa的侵袭性表型呈负相关。这些研究表明,MDC1作为一种表观遗传修饰因子调节AR转录活性,MDC1可能作为PCa的肿瘤抑制因子,并为辅助因子-AR信号通路机制提供了新的见解,有助于更好地理解MDC1在PCa中的功能。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/2471f43b8065/gkv394fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/90d09ded30db/gkv394fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/cf65ffe3765b/gkv394fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/cd3df6a52e37/gkv394fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/cd7de490e9dc/gkv394fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/5e5f2b8c4300/gkv394fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/50e71e95b3bb/gkv394fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/2471f43b8065/gkv394fig7.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/90d09ded30db/gkv394fig1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/cf65ffe3765b/gkv394fig2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/cd3df6a52e37/gkv394fig3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/cd7de490e9dc/gkv394fig4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/5e5f2b8c4300/gkv394fig5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/50e71e95b3bb/gkv394fig6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3ac3/4446443/2471f43b8065/gkv394fig7.jpg

相似文献

1
MDC1 functionally identified as an androgen receptor co-activator participates in suppression of prostate cancer.MDC1在功能上被鉴定为雄激素受体共激活因子,参与前列腺癌的抑制过程。
Nucleic Acids Res. 2015 May 26;43(10):4893-908. doi: 10.1093/nar/gkv394. Epub 2015 Apr 30.
2
The tumor suppressor ING1b is a novel corepressor for the androgen receptor and induces cellular senescence in prostate cancer cells.肿瘤抑制因子ING1b是雄激素受体的一种新型共抑制因子,并可诱导前列腺癌细胞发生细胞衰老。
J Mol Cell Biol. 2016 Jun;8(3):207-20. doi: 10.1093/jmcb/mjw007. Epub 2016 Mar 18.
3
Inhibition of MAPK-signaling pathway promotes the interaction of the corepressor SMRT with the human androgen receptor and mediates repression of prostate cancer cell growth in the presence of antiandrogens.抑制丝裂原活化蛋白激酶(MAPK)信号通路可促进共抑制因子SMRT与人类雄激素受体的相互作用,并在抗雄激素存在的情况下介导前列腺癌细胞生长的抑制。
J Mol Endocrinol. 2009 May;42(5):429-35. doi: 10.1677/JME-08-0084. Epub 2009 Feb 17.
4
Determinants of Gli2 co-activation of wildtype and naturally truncated androgen receptors.Gli2 共激活野生型和天然截断雄激素受体的决定因素。
Prostate. 2014 Oct;74(14):1400-10. doi: 10.1002/pros.22855. Epub 2014 Aug 11.
5
The corepressors silencing mediator of retinoid and thyroid hormone receptor and nuclear receptor corepressor are involved in agonist- and antagonist-regulated transcription by androgen receptor.共抑制因子类视黄醇和甲状腺激素受体沉默介质以及核受体共抑制因子参与雄激素受体对激动剂和拮抗剂调节的转录过程。
Mol Endocrinol. 2006 May;20(5):1048-60. doi: 10.1210/me.2005-0324. Epub 2005 Dec 22.
6
Phenethyl isothiocyanate inhibits androgen receptor-regulated transcriptional activity in prostate cancer cells through suppressing PCAF.苯乙基异硫氰酸酯通过抑制 PCAF 抑制前列腺癌细胞中雄激素受体调节的转录活性。
Mol Nutr Food Res. 2013 Oct;57(10):1825-33. doi: 10.1002/mnfr.201200810. Epub 2013 May 10.
7
Expression profiles and functional associations of endogenous androgen receptor and caveolin-1 in prostate cancer cell lines.雄激素受体和窖蛋白-1在前列腺癌细胞系中的表达谱和功能相关性。
Prostate. 2014 May;74(5):478-87. doi: 10.1002/pros.22767. Epub 2013 Dec 24.
8
Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.威尔姆斯肿瘤抑制基因WT1对雄激素信号通路的转录调控。
Anticancer Res. 2001 Jan-Feb;21(1A):1-10.
9
Changes in androgen receptor nongenotropic signaling correlate with transition of LNCaP cells to androgen independence.雄激素受体非基因组信号的变化与LNCaP细胞向雄激素非依赖性的转变相关。
Cancer Res. 2004 Oct 1;64(19):7156-68. doi: 10.1158/0008-5472.CAN-04-1121.
10
Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells.蛙皮素在前列腺癌细胞中激活p300组蛋白乙酰转移酶活性并使雄激素受体乙酰化。
Oncogene. 2006 Mar 30;25(14):2011-21. doi: 10.1038/sj.onc.1209231.

引用本文的文献

1
Angiomyolipomatous Lesions of the Nasal Cavity (Sinonasal Angioleiomyoma with Adipocytic Differentiation): A Multi-Institutional Immunohistochemical and Molecular Study.鼻腔血管肌脂瘤病变(具有脂肪细胞分化的鼻内血管平滑肌脂肪瘤):一项多机构免疫组织化学和分子研究。
Head Neck Pathol. 2024 Oct 14;18(1):93. doi: 10.1007/s12105-024-01700-y.
2
Angiomyolipomatous Lesions of the Nasal Cavity (Sinonasal Angioleiomyoma with Adipocytic Differentiation): A Multi-Institutional Immunohistochemical and Molecular Study.鼻腔血管平滑肌脂肪瘤性病变(伴脂肪细胞分化的鼻窦血管平滑肌瘤):一项多机构免疫组织化学和分子研究
Res Sq. 2024 Sep 8:rs.3.rs-4843357. doi: 10.21203/rs.3.rs-4843357/v1.
3

本文引用的文献

1
Androgen receptor splice variants activating the full-length receptor in mediating resistance to androgen-directed therapy.雄激素受体剪接变体在介导对雄激素靶向治疗的耐药性中激活全长受体。
Oncotarget. 2014 Mar 30;5(6):1646-56. doi: 10.18632/oncotarget.1802.
2
TBLR1 as an androgen receptor (AR) coactivator selectively activates AR target genes to inhibit prostate cancer growth.TBLR1 作为雄激素受体 (AR) 共激活因子,选择性地激活 AR 靶基因,抑制前列腺癌生长。
Endocr Relat Cancer. 2014 Jan 16;21(1):127-42. doi: 10.1530/ERC-13-0293. Print 2014 Feb.
3
Targeting the androgen receptor with siRNA promotes prostate cancer metastasis through enhanced macrophage recruitment via CCL2/CCR2-induced STAT3 activation.
MYSM1 acts as a novel co-activator of ERα to confer antiestrogen resistance in breast cancer.
MYSM1 作为 ERα 的新型共激活因子,赋予乳腺癌抗雌激素耐药性。
EMBO Mol Med. 2024 Jan;16(1):10-39. doi: 10.1038/s44321-023-00003-z. Epub 2023 Dec 15.
4
Androgen receptor contributes to repairing DNA damage induced by inflammation and oxidative stress in prostate cancer.雄激素受体有助于修复前列腺癌中由炎症和氧化应激诱导的DNA损伤。
Turk J Biol. 2023 Oct 11;47(5):325-335. doi: 10.55730/1300-0152.2667. eCollection 2023.
5
The Androgen Receptor Does Not Directly Regulate the Transcription of DNA Damage Response Genes.雄激素受体并不直接调控 DNA 损伤反应基因的转录。
Mol Cancer Res. 2023 Dec 1;21(12):1329-1341. doi: 10.1158/1541-7786.MCR-23-0358.
6
Recent Research Advances in Double-Strand Break and Mismatch Repair Defects in Prostate Cancer and Potential Clinical Applications.近年来前列腺癌双链断裂和错配修复缺陷的研究进展及其潜在的临床应用。
Cells. 2023 May 12;12(10):1375. doi: 10.3390/cells12101375.
7
Expression differences between proteins responsible for DNA damage repair according to the Gleason grade as a new heterogeneity marker in prostate cancer.根据Gleason分级,作为前列腺癌新的异质性标志物的DNA损伤修复相关蛋白之间的表达差异
Arch Med Sci. 2019 Nov 18;19(2):499-506. doi: 10.5114/aoms.2019.89773. eCollection 2023.
8
BAP18 facilitates CTCF-mediated chromatin accessible to regulate enhancer activity in breast cancer.BAP18 促进 CTCF 介导的染色质可及性,以调节乳腺癌中的增强子活性。
Cell Death Differ. 2023 May;30(5):1260-1278. doi: 10.1038/s41418-023-01135-y. Epub 2023 Feb 24.
9
Multiomics approach to profiling Sertoli cell maturation during development of the spermatogonial stem cell niche.采用多组学方法分析精原干细胞龛发育过程中支持细胞成熟的特征。
Mol Hum Reprod. 2023 Feb 28;29(3). doi: 10.1093/molehr/gaad004.
10
Lysine Acetyltransferases and Their Role in AR Signaling and Prostate Cancer.赖氨酸乙酰转移酶及其在 AR 信号转导和前列腺癌中的作用。
Front Endocrinol (Lausanne). 2022 Aug 17;13:886594. doi: 10.3389/fendo.2022.886594. eCollection 2022.
靶向雄激素受体的 siRNA 通过 CCL2/CCR2 诱导的 STAT3 激活增强巨噬细胞募集促进前列腺癌转移。
EMBO Mol Med. 2013 Sep;5(9):1383-401. doi: 10.1002/emmm.201202367. Epub 2013 Aug 27.
4
Oncogenic PAK4 regulates Smad2/3 axis involving gastric tumorigenesis.致癌性 PAK4 调节 Smad2/3 轴参与胃癌发生。
Oncogene. 2014 Jun 26;33(26):3473-84. doi: 10.1038/onc.2013.300. Epub 2013 Aug 12.
5
Differential androgen deprivation therapies with anti-androgens casodex/bicalutamide or MDV3100/Enzalutamide versus anti-androgen receptor ASC-J9(R) Lead to promotion versus suppression of prostate cancer metastasis.与抗雄激素 Casodex/比卡鲁胺或 MDV3100/恩扎卢胺相比,差异化雄激素剥夺疗法导致前列腺癌转移的促进或抑制。
J Biol Chem. 2013 Jul 5;288(27):19359-69. doi: 10.1074/jbc.M113.477216. Epub 2013 May 16.
6
The E3 ubiquitin ligase Siah2 contributes to castration-resistant prostate cancer by regulation of androgen receptor transcriptional activity.E3 泛素连接酶 Siah2 通过调节雄激素受体转录活性促进去势抵抗性前列腺癌的发生。
Cancer Cell. 2013 Mar 18;23(3):332-46. doi: 10.1016/j.ccr.2013.02.016.
7
EZH2 oncogenic activity in castration-resistant prostate cancer cells is Polycomb-independent.在去势抵抗性前列腺癌细胞中,EZH2 致癌活性是独立于 Polycomb 的。
Science. 2012 Dec 14;338(6113):1465-9. doi: 10.1126/science.1227604.
8
A transcriptional repressor co-regulatory network governing androgen response in prostate cancers.一个转录阻遏物共调控网络,调控前列腺癌中的雄激素反应。
EMBO J. 2012 Jun 13;31(12):2810-23. doi: 10.1038/emboj.2012.112. Epub 2012 Apr 24.
9
Epigenetic silencing of core histone genes by HERS in Drosophila.HERS 在果蝇中通过组蛋白基因的表观遗传沉默。
Mol Cell. 2012 Feb 24;45(4):494-504. doi: 10.1016/j.molcel.2011.12.029.
10
Inactivation of androgen-induced regulator ARD1 inhibits androgen receptor acetylation and prostate tumorigenesis.雄激素诱导调节剂 ARD1 的失活抑制雄激素受体乙酰化和前列腺肿瘤发生。
Proc Natl Acad Sci U S A. 2012 Feb 21;109(8):3053-8. doi: 10.1073/pnas.1113356109. Epub 2012 Feb 6.